ALCOR — Biocorp Production SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- €154.39m
- €157.50m
- €11.67m
Annual cashflow statement for Biocorp Production SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.31 | 0.96 | -1.24 | 0.294 | -0.651 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.114 | -0.051 | -0.016 | -0.011 | -0.015 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.821 | 0.29 | 0.426 | -1.51 | -0.417 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.12 | 1.89 | -0.168 | -0.45 | -0.218 |
| Capital Expenditures | -0.408 | -0.97 | -2.43 | -1 | -0.965 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.104 | 0.017 | -0.03 | -0.026 | 0.384 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.512 | -0.952 | -2.46 | -1.03 | -0.58 |
| Financing Cash Flow Items | -0.51 | -0.571 | -0.262 | 0.009 | 0.045 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.29 | -0.271 | 5.59 | -1.65 | 1.62 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.65 | 0.666 | 2.97 | -3.13 | 0.821 |